Literature DB >> 2158953

Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET.

A Luxen1, M Perlmutter, G T Bida, G Van Moffaert, J S Cook, N Satyamurthy, M E Phelps, J R Barrio.   

Abstract

Regioselective radiofluorodemercuration of the 6-mercurio derivative 5 with [18F]acetylhypofluorite afforded, after acidic hydrolysis, 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (6-FD, 1) with a radiochemical yield of 11% (decay corrected and based on the total amount of [18F]F2 recovered from the target). 6-FD was obtained with a chemical and radiochemical purity of greater than 99% and with a level of mercury in the final preparation of less than 20 ppb. Utilization of a remote, semiautomated production system, resulted in the preparation of a sterile, pyrogen-free product suitable for human injection after a synthesis time of 50 min.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158953     DOI: 10.1016/0883-2889(90)90191-i

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  17 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

3.  Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Egesta Lopci; Massimo Conte; Luca Foppiani; Stefania Sorrentino; Giovanni Morana; Mehrdad Naseri; Angelina Cistaro; Giampiero Villavecchia; Stefano Fanti; Alberto Garaventa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.

Authors:  Sophie Gabriel; Elise M Blanchet; Frédéric Sebag; Clara C Chen; Nicolas Fakhry; Arnaud Deveze; Anne Barlier; Isabelle Morange; Karel Pacak; David Taïeb
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-06       Impact factor: 3.478

Review 5.  Radiosyntheses using fluorine-18: the art and science of late stage fluorination.

Authors:  Erin L Cole; Megan N Stewart; Ryan Littich; Raphael Hoareau; Peter J H Scott
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

6.  A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.

Authors:  Alexander Kroiss; Daniel Putzer; Andreas Frech; Clemens Decristoforo; Christian Uprimny; Rudolf Wolfgang Gasser; Barry Lynn Shulkin; Christoph Url; Gerlig Widmann; Rupert Prommegger; Georg Mathias Sprinzl; Gustav Fraedrich; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236

Review 7.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

8.  PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs).

Authors:  G J Meyer; S L Waters; H H Coenen; A Luxen; B Maziere; B Langström
Journal:  Eur J Nucl Med       Date:  1995-12

9.  Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.

Authors:  Alexander Haug; Christoph J Auernhammer; Björn Wängler; Reinhold Tiling; Gerwin Schmidt; Burkhard Göke; Peter Bartenstein; Gabriele Pöpperl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

10.  Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.

Authors:  L Martiniova; E W Lai; D Thomasson; D O Kiesewetter; J Seidel; M J Merino; R Kvetnansky; K Pacak
Journal:  Endocr Regul       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.